C50
Conditions
Interventions
Group 1: Before starting primary chemotherapy suspicious axillary lymphnodes will be marked by a clip (HYDROMARK)
Sponsors
Universitätsfrauenklinik am Klinikum Südstadt
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: all patients diagnosed with invasive breast cancer (c/iT1-3, uni- or bilateral) at the university of rostock, who receive a primary systemic treatment and present with clinically/sonographically suspicious ipsilateral axillary lymphnodes (c/iN+) without distant metastases
Exclusion criteria
Exclusion criteria: male patients, pregnancy, age <18 years, T4-tumors, distant metastases (M1)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| concordance of primary minimal-invasive histologically proven suspicious axillary, clipmarked lymphnodes and sentinel lymphnodes after primary systemic treatment work measurement: surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| -creation of an oncologically safe concept to reduce axillary surgical radicalness after primary sytemic treatment in breast cancer patients with suspicious ipsilateral lymphnodes -rate of detection of axillary sentinel nodes after primary systemic treatment -predicitve value of the clipmarked lymphnode for metastatic disease in further lymphnodes after primary systemic treatment -adverse events caused by clipmarking lymphnodes | — |
Countries
Germany
Contacts
Public ContactSteffi Hartmann
Universitätsfrauenklinik am Klinikum Südstadt
Outcome results
None listed